ITGAX and systemic lupus erythematosus: This suggests that CD11c+ B cell induction depends quantitively on the extent of immune activation but can result in qualitative differences of abnormal and likely dysregulated immune activation as exemplified by CD11c+ B cells carrying increased PD-1 and PD-L1 in SLE.